Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Joëlle Blumberg"'
Autor:
Jacques de Mouzon, Pascal Maisonobe, Laetitia Martinerie, Luigi di Nicola, Joëlle Blumberg, Jean-Claude Carel
Publikováno v:
Horm Res Paediatr
Background: Gonadotropin-releasing hormone analogues (GnRHa) administered as depot formulations are the standard of care for children with central precocious puberty (CPP). Puberty resumes after treatment discontinuation, but little is known concerni
Autor:
Jean-Claude Carel, Co-Investigators, Nilani Liyanage, Najiba Lahlou, Evelyne Jacqz-Aigrain, Joëlle Blumberg, Delphine Zenaty
Publikováno v:
Hormone research in paediatrics. 86(3)
Background/Aims: To evaluate the efficacy and safety of a triptorelin pamoate (11.25 mg) 3-month formulation in the management of central precocious puberty (CPP) (TP Study) and to retrospectively compare it with a triptorelin acetate (11.25 mg) 3-mo
Autor:
François, Gayral, Jean-Pierre, Campion, Jean-Marc, Regimbeau, Joëlle, Blumberg, Pascal, Maisonobe, Philippe, Topart, Philippe, Wind, P, Valleur
Publikováno v:
Annals of Surgery. 250:872-877
Objective: Continuous intravenous infusion of somatostatin improves the natural course of digestive fistulae. Lanreotide 30 mg PR is a synthetic analogue of somatostatin with pharmacological activity extending to at least 10 days after intramuscular
Autor:
Maithé Tauber, Muriel Bougeard-Julien, Joëlle Blumberg, P Rochiccioli, Jean-Louis Chaussain, Jean-Claude Carel
Publikováno v:
Hormone Research in Paediatrics. 71:228-236
Background/Aims: The aim of the study was to evaluate the efficacy and safety of lanreotide prolonged release (PR) 30 mg (long-acting lanreotide) in girls with constitutional tall stature (CTS). Methods: This open label prospective study included 35
Publikováno v:
Clinical Therapeutics. 28:1485-1508
Background: Early identification of the biological activity of luteinizing hormone-releasing hormone (LHRH) paved the way for the synthesis of analogues with enhanced potency and biological properties. Early testing in animal models and humans provid
Publikováno v:
European Journal of Endocrinology. 154:119-124
Objective: Depot GnRH agonists are commonly used in the treatment of central precocious puberty (CPP). The triptorelin 11.25 mg 3-month depot, currently used in adult indications, had not previously been evaluated in CPP. Design: This was a multicent
Autor:
Ramuntcho Arotcarena, Muriel Bougeard-Julien, Patrick Hastier, Dermot O'Toole, Joëlle Blumberg, Eric Bartolie, Philippe Ruszniewski, Philippe Lévy
Publikováno v:
Pancreatology. 4:229-232
Background: Pain relapse after oral refeeding occurs in 21% of the patients with acute pancreatitis, and in 35% of those with CT Balthazar’s score ≧D [Gut 1997;40:262]. Somatostatin analogues may decrease the pain relapse rate by inhibiting exocr
Autor:
Stefan Benz, Kouji Tsuruta, E. von Dobschuetz, Niels Teich, Eric Bartolie, Joachim Mössner, Ourania Horaitis, Philippe Ruszniewski, Hannes P. Neeff, Dermot O'Toole, Hitoshi Nakajima, Ramuntcho Arotcarena, Anna Dziurkowska-Marek, Wen-Kui Yu, Patrick Hastier, Joëlle Blumberg, Volker Keim, Muriel Bougeard-Julien, Ning Li, Ewa Sierka, Caroline B. Kurtz, Richard G.H. Cotton, Teruo Nakamura, Axel Walch, Jieshou Li, Teresa Kacperek-Hartleb, Weiqin Li, Philippe Lévy, Andrzej J. Nowak, Ulrich Adam, Terumi Kamisawa, Tomasz Marek, Ewa Nowakowska-Duława, Robert Obermaier, Atsutake Okamoto, U.T. Hopt, Naoto Egawa, Masami Yoshiike
Publikováno v:
Pancreatology. 4:251-320
Autor:
Alexandria T. Phan, Martyn Caplin, Guido Rindi, Eva Sedlackova, Marianne Pavel, Alison Langley, Philippe Ruszniewski, Guillaume Cadiot, Markus Raderer, J. B. Cwikla, Joëlle Blumberg, Lucy Wall
Publikováno v:
Endocrine Abstracts.
Autor:
Lucy Wall, Martyn Caplin, Marianne Pavel, Séverine Martinez, Alison Langley, Guillaume Cadiot, Markus Raderer, Joëlle Blumberg, Guido Rindi, Philippe Ruszniewski, Edward M. Wolin, Jaume Capdevila, Eva Sedlackova, Alexandria T. Phan, Jarosław B. Ćwikła
Publikováno v:
The New England journal of medicine
Background Somatostatin analogues are commonly used to treat symptoms associated with hormone hypersecretion in neuroendocrine tumors; however, data on their antitumor effects are limited. Methods We conducted a randomized, double-blind, placebo-cont